Prognostic impact of epidermal growth factor receptor (EGFR) mutations in lung cancer

Treatment Outcome in Patients with Metastatic Non-Small Cell Lung Cancer at Presentation (Retrospective Study)

Prognostic Factors of Non-Small Cell Lung Cancer and Their Relation to the Clinical Outcomes

Correlation of Epidermal Growth Factor Receptor (EGFR), Mutation status and plasma level

Prognostic Factors for Platinum-Chemotherapy Response and Survival Outcomes in Patients with Advanced Stage Non-Small Cell Lung Cancer

Treatment Outcomes and Prognostic Factors of Patients with Locally Advanced Non-Small Cell Lung Cancer: A Single Institution Study

Osimertinib with Platinum Based Chemotherapy in Epidermal Growth Factor Receptor (EGFR)-Mutated Metastatic Non Small Cell Lung Cancer (NSCLC)

Gefitinib in Non-Small Cell Lung Cancer: A Prospective Study at South Egypt Cancer Institute

Prognostic Significance of Epidermal Growth Factor Receptor (EGFR) and HER-2 In Oral Squamous Cell Carcinoma

Role of epidermal growth factor receptor inhibitors in the treatment of lung cancer